Oaktree Acquisition III Life Sciences Free Cash Flow 2025-2024 | OACC

Oaktree Acquisition III Life Sciences free cash flow from 2025 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Oaktree Acquisition III Life Sciences Annual Free Cash Flow
Oaktree Acquisition III Life Sciences Quarterly Free Cash Flow
2024-09-30
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.019B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00